BARACLUDE

Baraclude is a prescription medicine used to treat chronic hepatitis B virus.

#SimilarOrganizations #Website #More

BARACLUDE

Industry:
Biotechnology Health Care Life Science Medical

Address:
New City, New York, United States

Country:
United States

Website Url:
http://www.baraclude.bmscustomerconnect.com

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Google Analytics Google Universal Analytics JsDelivr Cloudflare JS CDN JS AJAX Libraries API CrUX Top 50m GStatic Google Static Content CrUX Dataset Pound Sterling


Similar Organizations

not_available_image

Laboratorios Stein

Laboratorios Stein is a pharmaceutical company specializing in medicine production services.

not_available_image

Otezla

Otezlaยฎ is a prescription medicine approved for the treatment of patients with moderate

not_available_image

Reyataz

Reyataz is a prescription HIV type-1 medicine that is used with other anti-retroviral medicines to treat HIV.

tudorza-pressair-logo

TUDORZA PRESSAIR

TUDORZA PRESSAIR is a prescription medicine to treat chronic obstructive pulmonary disease.

not_available_image

US Pain and Spine Institute

US Pain and Spine Institute is a Hospital.

Official Site Inspections

http://www.baraclude.bmscustomerconnect.com

  • Host name: 165.89.235.20
  • IP address: 165.89.235.20
  • Location: Trenton United States
  • Latitude: 40.2187
  • Longitude: -74.7404
  • Metro Code: 504
  • Timezone: America/New_York
  • Postal: 08629

Loading ...

More informations about "Baraclude"

Home [www.bmscustomerconnect.com]

Bristol Myers Squibb is committed to providing you with useful information about our products and helping appropriate patients get access to reimbursement support.See details»

Baraclude - Crunchbase Company Profile & Funding

Baraclude is a prescription medicine used to treat chronic hepatitis B virus. New City, New York, United States; Private; www.baraclude.bmscustomerconnect.com ; 2,963,406See details»

HIGHLIGHTS OF PRESCRIBING INFORMATION BARACLUDE See โ€ฆ

A For doses less than 0.5 mg, BARACLUDE Oral Solution is recommended. b If administered on a hemodialysis day, administer BARACLUDE after the hemodialysis session. Although there โ€ฆSee details»

Bristol-Myers Squibb - Overview, News & Similar companies

Www.bmscustomerconnect.com. Revenue $248.6 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. No recent news or media ... Popular Searches Bristol-Myers Squibb โ€ฆSee details»

Baraclude - Drug pipelines, Patents, Clinical trials - Synapse

Jul 17, 2024 New York, United States | www.baraclude.bmscustomerconnect.com. Last update 11 Jul 2024See details»

Details for: BARACLUDE - Drug and Health Products Portal

Product name: BARACLUDE. Company name: BRISTOL-MYERS SQUIBB CANADA. DIN: 02282224. Status: Marketed. Status date: 2006-09-12. Active ingredient(s) Strength; โ€ฆSee details»

Connect2BMS

Population Health and Health Equity Resources. At Bristol Myers Squibb, weโ€™re committed to supporting our customers through dedicated Account teams and patient-focused educational โ€ฆSee details»

PRODUCT MONOGRAPH - Bristol Myers Squibb

Double-blind treatment with BARACLUDE 0.5 mg/day (n=679), BARACLUDE 1 mg/day (n=183), or lamivudine (n=858) for up totwo years (Studies AI463022, for AI463027 nucleoside-naïve โ€ฆSee details»

Consumer Information for: BARACLUDE - Drug and Health โ€ฆ

The usual dose of BARACLUDE Tablets in adults and children over 16 years of age is either one or two 0.5 mg tablets once daily by mouth. Your dose may be lower or you may take โ€ฆSee details»

Tips From a Pharmacist: Accessing Affordable Hepatitis Treatment

Baraclude Patient Assistance Program www.baraclude.bmscustomerconnect.com 1-855-898-0267 Award up to $400/month Eligible if you: Currently have insurance Do not have Medicare โ€ฆSee details»

Baraclude Medical Information for Bristol-Myers Squibb

Baraclude ® (entecavir monohydrate) 0.05 mg/ mL Oral Solution Baraclude ® (entecavir monohydrate) 0.5 mg Film Coated Tablets Baraclude ® (entecavir monohydrate) 1.0 mg Film โ€ฆSee details»

3/31/22, 10:58 PM Baraclude - globalcarepharmacy.ca

BARACLUDE is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults who also. have active liver damage. What it does: BARACLUDE may lower the amount โ€ฆSee details»

Bristol-Myers Squibb: Employee Directory | ZoomInfo.com

Bristol-Myers Squibb Contact Info: Phone number: (866) 279-4730 Website: www.bmscustomerconnect.com What does Bristol-Myers Squibb do? US Healthcare โ€ฆSee details»

Hep Drug Pages - Hep

Mar 4, 2019 General Info. Baraclude was approved by the U.S. Food and Drug Administration for use by adults with chronic hepatitis B on March 29, 2005. Approved for children โ‰ฅ 2 years โ€ฆSee details»

Baraclude - AidsNet

Microsoft Word - Baraclude.doc Author: cbontempo Created Date: 7/2/2010 9:56:17 AM ...See details»

IMPORTANT: PLEASE READ - Bristol Myers Squibb

Sep 23, 2020 BARACLUDE tablets: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, magnesium stearate, titanium dioxide, hypromellose, polyethylene โ€ฆSee details»

Entecavir - Wikipedia

Entecavir, sold under the brand name Baraclude, is an antiviral medication used in the treatment of hepatitis B virus infection. [6] In those with both HIV/AIDS and hepatitis B virus antiretroviral โ€ฆSee details»

Baraclude Factsheet, Uses & Common Side Effects | Rexall

As Canada's trusted pharmacy, Rexall provides detailed drug factsheets for Baraclude with common uses, dosage instructions, side effects & drug interactions.See details»

baraclude.bmscustomerconnect.com - Baraclude โ€ฆ

Baraclude.bmscustomerconnect.com has not yet implemented SSL encryption. ADULT CONTENT INDICATORS Availability or unavailability of the flaggable/dangerous content on โ€ฆSee details»

Get Baraclude.bmscustomerconnect.com news - Feedreader

It seems that Baraclude Bmscustomerconnect content is notably popular in USA. We havenโ€™t detected security issues or inappropriate content on Baraclude.bmscustomerconnect.com and โ€ฆSee details»

linkstock.net © 2022. All rights reserved